These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20976941)

  • 21. New gene therapy technique shows some muscle.
    Schub T
    Lab Anim (NY); 2004 Sep; 33(8):8-9. PubMed ID: 15334094
    [No Abstract]   [Full Text] [Related]  

  • 22. [Gene therapy to muscle diseases: perspective and issues on basic research].
    Takeda S
    Nihon Rinsho; 1997 Dec; 55(12):3114-9. PubMed ID: 9436420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Duchenne muscular dystrophy].
    Ishiura S; Sugita H
    No To Shinkei; 1991 May; 43(5):405-9. PubMed ID: 1910927
    [No Abstract]   [Full Text] [Related]  

  • 24. Gene therapy. Muscle transfection made easy.
    Partridge TA
    Nature; 1991 Aug; 352(6338):757-8. PubMed ID: 1881432
    [No Abstract]   [Full Text] [Related]  

  • 25. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.
    Matsumura K; Campbell KP
    Muscle Nerve; 1994 Jan; 17(1):2-15. PubMed ID: 8264699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery.
    Abmayr S; Gregorevic P; Allen JM; Chamberlain JS
    Mol Ther; 2005 Sep; 12(3):441-50. PubMed ID: 16099410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity.
    Cox GA; Cole NM; Matsumura K; Phelps SF; Hauschka SD; Campbell KP; Faulkner JA; Chamberlain JS
    Nature; 1993 Aug; 364(6439):725-9. PubMed ID: 8355788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current understanding of dystrophin-related muscular dystrophy and therapeutic challenges ahead.
    Zhou GQ; Xie HQ; Zhang SZ; Yang ZM
    Chin Med J (Engl); 2006 Aug; 119(16):1381-91. PubMed ID: 16934185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipofection of a cDNA plasmid containing the dystrophin gene lowers intracellular free calcium and calcium leak channel activity in mdx myotubes.
    McCarter GC; Denetclaw WF; Reddy P; Steinhardt RA
    Gene Ther; 1997 May; 4(5):483-7. PubMed ID: 9274726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The childhood muscular dystrophies: making order out of chaos.
    Tsao CY; Mendell JR
    Semin Neurol; 1999; 19(1):9-23. PubMed ID: 10711985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatments for muscular dystrophy: increased treatment options for Duchenne and related muscular dystropies.
    Wells DJ
    Gene Ther; 2008 Aug; 15(15):1077-8. PubMed ID: 18528429
    [No Abstract]   [Full Text] [Related]  

  • 32. The principles of gene therapy in Duchenne muscular dystrophy.
    Karpati G; Acsadi G
    Clin Invest Med; 1994 Oct; 17(5):499-509. PubMed ID: 7867254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myoblast transfer in the treatment of Duchenne's muscular dystrophy.
    Mendell JR; Kissel JT; Amato AA; King W; Signore L; Prior TW; Sahenk Z; Benson S; McAndrew PE; Rice R
    N Engl J Med; 1995 Sep; 333(13):832-8. PubMed ID: 7651473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Introduction of rod-deleted dystrophin cDNA, delta DysM3, into mdx skeletal muscle using adenovirus vector].
    Yuasa K; Ishii A; Miyagoe Y; Takeda S
    Nihon Rinsho; 1997 Dec; 55(12):3148-53. PubMed ID: 9436426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developments in gene therapy for muscular dystrophy.
    Hartigan-O'Connor D; Chamberlain JS
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):223-38. PubMed ID: 10679969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene delivery goes global.
    Thomas CE
    Nat Med; 2004 Aug; 10(8):782-3. PubMed ID: 15286775
    [No Abstract]   [Full Text] [Related]  

  • 37. [Development of new therapy on muscular dystrophy].
    Takeda S
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1154-6. PubMed ID: 12235824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene transfer therapy for heritable disease: cell and expression targeting.
    Mitani K; Clemens PR; Moseley AB; Caskey CT
    Philos Trans R Soc Lond B Biol Sci; 1993 Feb; 339(1288):217-24. PubMed ID: 8097051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Codon optimization of the microdystrophin gene for Duchene muscular dystrophy gene therapy.
    Athanasopoulos T; Foster H; Foster K; Dickson G
    Methods Mol Biol; 2011; 709():21-37. PubMed ID: 21194019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myoblast transfer in DMD: problems in the interpretation of efficiency.
    Karpati G; Holland P; Worton RG
    Muscle Nerve; 1992 Oct; 15(10):1209-10. PubMed ID: 1406777
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.